Improved outcomes for Kaposi sarcoma using pegylated liposomal doxorubicin | Matthew Coldiron
1 Bekeken
• 06/15/23
0
0
insluiten
administrator
abonnees
A study conducted in Mozambique shows pegylated liposomal doxorubicin (PLD) was safe, well-tolerated and effective as first-line treatment for Kaposi’s sarcoma, a common HIV-associated malignancy.
Laat meer zien
Facebook Reacties
SORT BY-
Top Reacties
-
Laatste Reacties